Rikiya Nakamura

2.2k citations

61 papers · 984 indexed · h-index 19

Oncology top 5%
- HER2/EGFR in Cancer Research 17
- Cancer Treatment and Pharmacology 14
- Lymphatic System and Diseases 5
- PARP inhibition in cancer therapy 4
Cancer Research top 10%
- Breast Cancer Treatment Studies 28
Pulmonary and Respiratory Medicine top 10%
- Advanced Breast Cancer Therapies 13
Genetics top 10%
Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 11
Radiology, Nuclear Medicine and Imaging
- MRI in cancer diagnosis 4

Co-authors: Naohito Yamamoto Masaru Miyazaki Manabu Arai Norikazu Masuda Masahiro Sakakibara Takeshi Nagashima Hiroji Iwata Yukio Nakatani
Cited by: Oncology Cancer Research Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Oncology (2 papers)Cancer Research (3 papers)Annals of Oncology (2 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Rikiya Nakamura

57 papers receiving 966 citations

Peers

Countries citing papers authored by Rikiya Nakamura

Since Specialization

Citations

This map shows the geographic impact of Rikiya Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikiya Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikiya Nakamura more than expected).

Fields of papers citing papers by Rikiya Nakamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikiya Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikiya Nakamura. The network helps show where Rikiya Nakamura may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rikiya Nakamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rikiya Nakamura Line = papers co-authored together Rikiya Nakamura links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sporadic Breast Angiosarcoma With MYC Amplification on Extrachromosomal Circular DNA Detected Using Nanopore Sequencing in an Adolescent Female Genes Chromosomes and Cancer ·Naohiro Makise,Jason Lin,Hajime Kageyama,M. Oikawa,Takahiro Sugiyama,Hidetada Kawana,Akinobu Araki,Shouko Hayama,Rikiya Nakamura,Hideyuki Kinoshita,Hiroto Kamoda,Yoko Hagiwara,Tsukasa Yonemoto,Masahito Kawazu,Makiko Itami	2024	1
2	The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients BMC Cancer ·Shouko Hayama,Rikiya Nakamura,Takayuki Ishige,Takafumi Sangai,Masahiro Sakakibara,Hiroshi Fujimoto,Emi Ishigami,Takahito Masuda,Ayako Nakagawa,Ryotaro Teranaka,Satoshi Ota,Sakae Itoga,Naohito Yamamoto,Takeshi Nagashima,Masayuki Otsuka	2023	3
3	Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer Breast Cancer Research and Treatment ·Shinsuke Sasada,Naoto Kondo,Hiroya Hashimoto,Yuko Takahashi,Kaori Terata,Kumiko Kida,Yasuaki Sagara,Takayuki Ueno,Keisei Anan,Akihiko Suto,Chizuko Kanbayashi,Mina Takahashi,Rikiya Nakamura,Toshiyuki Ishiba,Michiko Tsuneizumi,Seiichiro Nishimura,Yoichi Naito,Fumikata Hara,Tadahiko Shien,Hiroji Iwata	2023	2
4	Utility of the intraflap perfusion procedure for abdominal free flap in unilateral breast reconstruction Journal of Plastic Reconstructive & Aesthetic Surgery ·Hideki Tokumoto,Shinsuke Akita,Kentaro Kosaka,Rikiya Nakamura,Naohito Yamamoto,Yoshitaka Kubota,Nobuyuki Mitsukawa	2023	1
5	Investigation of the Association Between Breast Cancer-Related Lymphedema and the Side Effects of Taxane-Based Chemotherapy Using Indocyanine Green Lymphography Lymphatic Research and Biology ·Hideki Tokumoto,Shinsuke Akita,Rikiya Nakamura,Naohito Yamamoto,Yoshitaka Kubota,Nobuyuki Mitsukawa	2022	7
6	Lymphatic dysfunction on indocyanine green lymphography in breast cancer patients undergoing sentinel lymph node biopsy Journal of Plastic Reconstructive & Aesthetic Surgery ·Hideki Tokumoto,Shinsuke Akita,Rikiya Nakamura,Naohito Yamamoto,Yoshitaka Kubota,Nobuyuki Mitsukawa	2021	2
7	Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study) Investigational New Drugs ·Toshinari Yamashita,Hidetoshi Kawaguchi,Norikazu Masuda,Masahiro Kitada,Kazutaka Narui,Masaya Hattori,Tetsuhiro Yoshinami,Nobuki Matsunami,Kazuhiro Yanagihara,Teru Kawasoe,Takeshi Nagashima,Hiroko Bando,Hiroshi Yano,Yoshie Hasegawa,Rikiya Nakamura,Masahiro Kashiwaba,Satoshi Morita,Shinji Ohno,Masakazu Toi	2020	8
8	Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy Translational Oncology ·Akihiko Shimomura,Kan Yonemori,Masayuki Yoshida,Teruhiko Yoshida,Hiroyuki Yasojima,Norikazu Masuda,Kenjiro Aogi,Masato Takahashi,Yoichi Naito,Satoru Shimizu,Rikiya Nakamura,Akinobu Hamada,Hirofumi Michimae,Jun Hashimoto,Harukaze Yamamoto,Asuka Kawachi,Chikako Shimizu,Yasuhiro Fujiwara,Kenji Tamura	2019	7
9	Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients International Journal of Clinical Oncology ·Norikazu Masuda,Kenichi Inoue,Rikiya Nakamura,Yoshiaki Rai,Hirofumi Mukai,Shinji Ohno,Fumikata Hara,Yuko Mori,Satoshi Hashigaki,Yasuaki Muramatsu,Takashi Nagasawa,Yoshiko Umeyama,Xin Huang,Hiroji Iwata	2018	41
10	Efficacy and safety of olaparib combined with eribulin in patients with advanced or metastatic triple negative breast cancer (TNBC) previously treated with anthracyclines and taxanes: The final analysis of a Japanese phase I/II trial Annals of Oncology ·K. Aogi,Kan Yonemori,Mina Takahashi,Norikazu Masuda,Yoichi Naito,Shinichi Shimizu,Rikiya Nakamura,H. Yamamoto,Akinobu Hamada,Hirofumi Michimae,Keita Tamura,Tamie Sukigara,Ritsuko Nagasaka,Yasuhiro Fujiwara	2017	2
11	Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in patients with HER2-positive primary breast cancer (A randomized, phase 2 study; JBCRG-20) Annals of Oncology ·Norikazu Masuda,Shoichiro Ohtani,Toshimi Takano,Kenichi Inoue,Eiji Suzuki,Rikiya Nakamura,Hiroko Bando,(unknown),Kazunari Ishida,Takashi Yamanaka,Katsumasa Kuroi,Hiroyuki Yasojima,Haruo Kasai,T. Takasuka,Takaki Sakurai,Tatsuki R. Kataoka,Satoshi Morita,Shinji Ohno,Masakazu Toi	2017	1
12	The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer, 2015 edition Breast Cancer ·Tomohiko Aihara,Tatsuya Toyama,Masato Takahashi,Yutaka Yamamoto,Fumikata Hara,Hiromitsu Akabane,Tomomi Fujisawa,Takashi Ishikawa,Shigenori E. Nagai,Rikiya Nakamura,Junji Tsurutani,Yoshinori Ito,Hirofumi Mukai	2016	68
13	Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors The Breast ·Rikiya Nakamura,Naohito Yamamoto,Nobumitsu Shiina,Toshiko Miyaki,Dai Ikebe,Makiko Itami,Takashi Shida,Masaru Miyazaki	2015	11
14	Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis Breast Cancer Research and Treatment ·Naoki Niikura,Naoki Hayashi,Norikazu Masuda,Seiki Takashima,Rikiya Nakamura,Kenichi Watanabe,Chizuko Kanbayashi,M. Ishida,Yasuo Hozumi,Michiko Tsuneizumi,Naoto Kondo,Yoichi Naito,Yayoi Honda,Akira Matsui,Tomomi Fujisawa,Risa Oshitanai,Hiroyuki Yasojima,Yutaka Tokuda,Shigehira Saji,Hiroji Iwata	2014	133
15	Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis Breast Cancer Research and Treatment ·Naoki Hayashi,Naoki Niikura,Norikazu Masuda,Seiki Takashima,Rikiya Nakamura,Kenichi Watanabe,Chizuko Kanbayashi,M. Ishida,Yasuo Hozumi,Michiko Tsuneizumi,Naoto Kondo,Yoichi Naito,Yayoi Honda,Akira Matsui,Tomomi Fujisawa,Risa Oshitanai,Hiroyuki Yasojima,Hideko Yamauchi,Shigehira Saji,Hiroji Iwata	2014	28
16	A case of paget's disease of the nipple after breast-conserving treatment Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Yoshihiro Watanabe,Naohito Yamamoto,Rikiya Nakamura,Yasuhide Onai,Takahiro Sugiyama,Masaru Miyazaki	2012	0
17	Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management Breast Cancer ·Naohito Yamamoto,Hiroshi Fujimoto,Rikiya Nakamura,Manabu Arai,Atsushi Yoshii,Sachiko Kaji,Makiko Itami	2010	45
18	Breast-Conserving Surgery Using Projection and Reproduction Techniques of Surgical-Position Breast MRI in Patients with Ductal Carcinoma In Situ of the Breast Journal of the American College of Surgeons ·Masahiro Sakakibara,Takeshi Nagashima,Takafumi Sangai,Rikiya Nakamura,Hiroshi Fujimoto,Manabu Arai,Toshiki Kazama,Hideyuki Hashimoto,Yukio Nakatani,Masaru Miyazaki	2008	42
19	Ectopic breast tissue in axillary lymph node Breast Cancer ·Masami Kadowaki,Takeshi Nagashima,Hiroto Sakata,Masahiro Sakakibara,Takafumi Sangai,Rikiya Nakamura,Hiroshi Fujimoto,Manabu Arai,Yasuhide Onai,Yuichirou Nagai,Yukimasa Miyazawa,Masaru Miyazaki	2007	7
20	Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients European Journal of Radiology ·Takeshi Nagashima,Masahiro Sakakibara,Rikiya Nakamura,Manabu Arai,Masami Kadowaki,Toshiki Kazama,Yukio Nakatani,Keiji Koda,Masaru Miyazaki	2006	28

About Rikiya Nakamura

Rikiya Nakamura is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 61 papers that have together received 984 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (28 papers), HER2/EGFR in Cancer Research (17 papers), Cancer Treatment and Pharmacology (14 papers), Advanced Breast Cancer Therapies (13 papers), Breast Lesions and Carcinomas (11 papers), Lymphatic System and Diseases (5 papers), MRI in cancer diagnosis (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Oncology (622 citations), Cancer Research (265 citations) and Pulmonary and Respiratory Medicine (360 citations). Rikiya Nakamura has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Naohito Yamamoto, Masaru Miyazaki, Manabu Arai, Norikazu Masuda, Masahiro Sakakibara, Takeshi Nagashima, Hiroji Iwata, Yukio Nakatani, Hiroshi Fujimoto and Makiko Itami. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact